Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.
暂无分享,去创建一个
B. Gazzard | P. Klenerman | P. Simmonds | H. Günthard | R. Phillips | F. Powrie | H. Uhlig | J. Fox | A. Rauch | K. Gärtner | J. Frater | P. Goulder | N. Khanna | Krista Adelmann | J. Ussher | A. Kurioka | M. Hühn | C. Cosgrove | A. Steel | T. Hansen | J. Fergusson | Yu-Hoi Kang | R. Phillips
[1] P. Klenerman,et al. /MAIT cells in HIV infection ++ Early and nonreversible decrease of CD161 , 2013 .
[2] L. Pirofski,et al. CD8+ T cells and Risk for Bacterial Pneumonia and All-Cause Mortality Among HIV-Infected Women , 2012, Journal of acquired immune deficiency syndromes.
[3] P. Klenerman,et al. Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. , 2012, Blood.
[4] K. Metzner,et al. Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] P. Klenerman,et al. CD161-Expressing Human T Cells , 2011, Front. Immun..
[6] S. Travis,et al. IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease , 2011, The Journal of experimental medicine.
[7] C. Bodemer,et al. Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity , 2011, Science.
[8] P. Georgel,et al. The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. , 2011, Molecular immunology.
[9] O. Lantz,et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. , 2011, Blood.
[10] P. Nigam,et al. Loss of IL-17–Producing CD8 T Cells during Late Chronic Stage of Pathogenic Simian Immunodeficiency Virus Infection , 2011, The Journal of Immunology.
[11] L. Cosmi,et al. CD161 is a marker of all human IL‐17‐producing T‐cell subsets and is induced by RORC , 2010, European journal of immunology.
[12] O. Lantz,et al. Antimicrobial activity of mucosal-associated invariant T cells , 2010, Nature Immunology.
[13] S. Pittaluga,et al. Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections , 2010, PLoS pathogens.
[14] Matthew S. Cook,et al. Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells , 2010, PLoS biology.
[15] J. Flint,et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties , 2010, Proceedings of the National Academy of Sciences.
[16] E. Estey,et al. A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. , 2009, Immunity.
[17] M. Lederman,et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. , 2009, The Journal of infectious diseases.
[18] O. Lantz,et al. Stepwise Development of MAIT Cells in Mouse and Human , 2009, PLoS biology.
[19] Polina Golland,et al. Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning , 2009, Proceedings of the National Academy of Sciences.
[20] Mahavir Singh,et al. Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. , 2008, The Journal of infectious diseases.
[21] C. Loddenkemper,et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients , 2008, Gut.
[22] T. Chun,et al. Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses , 2008, Mucosal Immunology.
[23] Jay K Kolls,et al. Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut , 2008, Nature Medicine.
[24] B. Walker,et al. CD161 expression on hepatitis C virus–specific CD8+ T cells suggests a distinct pathway of T cell differentiation , 2008, Hepatology.
[25] R. Xavier,et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.
[26] G. Walzl,et al. Correlates for disease progression and prognosis during concurrent HIV/TB infection. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[27] A. Samri,et al. Trapping and apoptosis of novel subsets of memory T lymphocytes expressing CCR6 in the spleen of HIV-infected patients. , 2007, Blood.
[28] R. Locksley,et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.
[29] J. Brenchley,et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.
[30] M. Markowitz,et al. Erratum: Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection (PloS Medicine 3,12 DOI:10.1371/journal.pmed. 0030484) , 2006 .
[31] M. Markowitz,et al. Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection , 2006, PLoS medicine.
[32] M. Markowitz,et al. Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acuteand Early Human Immunodeficiency Virus Type 1 Infection , 2006, Journal of Virology.
[33] K. Herrmann,et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[34] J. Church. CD4+ T Cell Depletion During All Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2005, Pediatrics.
[35] Raymond Lister,et al. Grand challenges , 2005, SGCS.
[36] Pam Sonnenberg,et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. , 2005, The Journal of infectious diseases.
[37] Christine Hogan,et al. Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.
[38] D. Price,et al. CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.
[39] P. Schwarzenberger,et al. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. , 2004, The Journal of infectious diseases.
[40] Mario Roederer,et al. T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis , 2004, Journal of Virology.
[41] T. Reinhart,et al. Productive infection of dendritic cells by simian immunodeficiency virus in macaque intestinal tissues , 2003, The Journal of pathology.
[42] J. Flamm,et al. Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.
[43] Olivier Lantz,et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 , 2003, Nature.
[44] D. Kasper,et al. CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism 1 , 2003, The Journal of Immunology.
[45] L. Mayer,et al. Colonic epithelial cells are a major site of macrophage inflammatory protein 3α (MIP-3α) production in normal colon and inflammatory bowel disease , 2002, Gut.
[46] L. Mayer,et al. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. , 2002, Gut.
[47] J. Margolick,et al. Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.
[48] M. Nowak,et al. Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy , 1999, Journal of Virology.
[49] M. Roth,et al. Costimulation of Naive CD8+ Lymphocytes Induces CD4 Expression and Allows Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.
[50] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[51] M. Roth,et al. Costimulation of Naive CD 8 1 Lymphocytes Induces CD 4 Expression and Allows Human Immunodeficiency Virus Type 1 Infection , 1998 .
[52] H. Nomiyama,et al. Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC* , 1997, The Journal of Biological Chemistry.
[53] J. Greenspan,et al. HIV-related oral disease , 1996, The Lancet.
[54] P. Simmonds,et al. Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1 , 1996, The Lancet.
[55] B. Gazzard,et al. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. , 1995, Gut.
[56] M. Zeitz,et al. Abnormalities in subset distribution, activation, and differentiation of T ceils isolated from large intestine biopsies in HIV infection , 1994 .
[57] M. Zeitz,et al. Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. The Berlin Diarrhoea/Wasting Syndrome Study Group. , 1994, Clinical and experimental immunology.
[58] M. Johnson,et al. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection , 1993, Clinical and experimental immunology.
[59] R. Pounder,et al. Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease. , 1993, Scandinavian journal of gastroenterology.
[60] M. Baseler,et al. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. , 1991, Journal of immunology.
[61] B. Gazzard,et al. Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients. , 1989, Gut.